Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.89M | $2.76M | $3.60M | $3.72M | $2.48M | $4.50M | $5.17M | $6.21M | $7.01M | $8.98M |
| Revenue growth | — | 45.8% | 30.4% | 3.3% | -33.2% | 80.9% | 15.0% | 20.0% | 13.0% | 28.1% |
| Gross profit | $102K | $585K | $995K | $756K | $83.0K | $754K | $1.12M | $1.81M | $1.51M | $2.65M |
| Gross margin | 5.4% | 21.2% | 27.6% | 20.3% | 3.3% | 16.8% | 21.6% | 29.1% | 21.5% | 29.5% |
| Operating income | -$7.65M | -$8.23M | -$7.61M | -$9.82M | -$10.4M | -$14.7M | -$18.7M | -$21.1M | -$33.5M | -$49.6M |
| Operating margin | -403.8% | -298.2% | -211.4% | -263.8% | -417.7% | -327.4% | -361.9% | -340.7% | -478.0% | -552.6% |
| Net income | -$8.46M | -$8.44M | -$7.24M | -$10.0M | -$10.5M | -$14.9M | -$18.5M | -$19.9M | -$32.0M | -$48.8M |
| Net margin | -446.7% | -305.6% | -201.1% | -269.8% | -424.3% | -331.9% | -357.6% | -321.0% | -456.6% | -543.3% |
| EPS (diluted) | -$207.72 | -$34.98 | -$16.67 | -$4.80 | -$6.97 | -$2.03 | -$2.35 | -$0.82 | -$0.76 | -$0.76 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$7.50M | -$8.13M | -$7.61M | -$9.81M | -$9.08M | -$13.2M | -$15.5M | -$16.4M | -$21.9M | -$35.1M |
| Capital expenditures | $49.0K | $258K | $67.0K | $284K | $88.0K | $344K | $473K | $381K | $1.40M | $1.66M |
| Free cash flow | -$7.54M | -$8.39M | -$7.67M | -$10.1M | -$9.17M | -$13.6M | -$16.0M | -$16.8M | -$23.3M | -$36.8M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7.52M | $3.71M | $9.38M | $5.51M | $12.6M | $12.0M | $4.63M | $9.64M | $18.9M | $8.94M |
| Total assets | $9.41M | $6.11M | $12.3M | $9.88M | $17.8M | $39.7M | $24.7M | $47.6M | $46.8M | $69.4M |
| Total liabilities | $5.37M | $3.11M | $3.52M | $4.50M | $5.61M | $6.18M | $7.26M | $8.14M | $10.7M | $14.2M |
| Shareholders' equity | $4.04M | $2.73M | $8.76M | $5.38M | $12.2M | $33.5M | $17.4M | $39.5M | $36.1M | $55.2M |
| Retained earnings | -$132M | -$140M | -$148M | -$158M | -$168M | -$183M | -$202M | -$222M | -$254M | -$302M |
| Shares (wtd avg diluted) | 42.7B | 1.48M | 38.4M | 3.92M | 3.28M | 7.35M | 7.87M | 24.3M | 41.9M | 64.3M |
Every figure is extracted from InspireMD, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.